Reversible pulmonary arterial hypertension likely related to long-term, low-dose dasatinib treatment for chronic myeloid leukaemia

Leuk Res. 2012 Jan;36(1):e4-6. doi: 10.1016/j.leukres.2011.08.007. Epub 2011 Sep 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Dasatinib
  • Dose-Response Relationship, Drug
  • Electrocardiography
  • Familial Primary Pulmonary Hypertension
  • Female
  • Humans
  • Hypertension, Pulmonary / chemically induced*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Middle Aged
  • Pyrimidines / administration & dosage*
  • Pyrimidines / adverse effects*
  • Remission, Spontaneous
  • Thiazoles / administration & dosage*
  • Thiazoles / adverse effects*
  • Time Factors

Substances

  • Antineoplastic Agents
  • Pyrimidines
  • Thiazoles
  • Dasatinib